Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Jul 17, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$4.62B
sum of reported positions
Reported positions
449
Changes vs prior quarter
335
44 new · 28 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 134 measured positions in 8 quarters, the typical new or larger position finished −3.3 pts against the S&P 500 and 40% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
VANGUARD INDEX FDS | 1.18M | $357M | 7.7% |
ISHARES TR | 3.68M | $355M | 7.7% |
ISHARES INC | 2.52M | $209M | 4.5% |
ISHARES TR | 259K | $194M | 4.2% |
SELECT SECTOR SPDR TR | 925K | $176M | 3.8% |
ISHARES TR | 2.19M | $175M | 3.8% |
SPDR SERIES TRUST | 6.82M | $171M | 3.7% |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $3.61B | $4.62B |
| Positions | 433 | 449 |
| Biggest line | — | VANGUARD INDEX FDS 8% |
SPDR SERIES TRUST |
| 1.64M |
| $158M |
| 3.4% |
JOHN HANCOCK EXCHANGE TRADED | 1.52M | $135M | 2.9% |
| 426K | $123M | 2.7% |
| 344K | $68.8M | 1.5% |
| 177K | $66.2M | 1.4% |
| 135K | $64.4M | 1.4% |
SELECT SECTOR SPDR TR | 336K | $62.2M | 1.3% |
VANGUARD INDEX FDS | 703K | $60.6M | 1.3% |
SELECT SECTOR SPDR TR | 340K | $53.9M | 1.2% |
| 90K | $52.2M | 1.1% |
VANECK ETF TRUST | 969K | $49.9M | 1.1% |
| 133K | $47.5M | 1.0% |
| 63K | $45.4M | 1.0% |
AMERICAN CENTY ETF TR | 493K | $44.4M | 1.0% |
SELECT SECTOR SPDR TR | 391K | $41.8M | 0.9% |
| 175K | $41.7M | 0.9% |
INVESCO EXCHANGE TRADED FD T | 193K | $41M | 0.9% |
INVESCO EXCHANGE TRADED FD T | 746K | $40.3M | 0.9% |
SPDR SERIES TRUST
26K → 20K shares (−23%)
Biocryst Pharmaceuticals (BCRX)
38K → 47K shares (+23%)
Constellation Energy (CEG)
1,629 → 1,829 shares (+12%)
Astrazeneca (AZN)
2,831 → 2,381 shares (−16%)
Burlington Stores (BURL)
1,417 shares
ISHARES TR
21K → 12K shares (−42%)
ISHARES TR
3,142 → 3,252 shares (+4%)
Sempra (SRE)
4,786 shares
Revolution Medicines (RVMD)
2,369 shares
Kinder Morgan (KMI)
13K → 14K shares (+3%)
BP (BP)
12K → 12K shares (−1%)
FIDELITY MERRIMACK STR TR
8,506 → 8,391 shares (−1%)
J P MORGAN EXCHANGE TRADED F
7,897 → 7,687 shares (−3%)
Newmont (NEM)
4,050 → 4,113 shares (+2%)
General Dynamics (GD)
1,035 → 1,078 shares (+4%)
Vertex Pharmaceuticals (VRTX)
648 → 759 shares (+17%)
ISHARES TR
8,077 → 6,778 shares (−16%)
L3Harris (LHX)
1,309 → 1,289 shares (−2%)
FedEx (FDX)
1,139 → 1,196 shares (+5%)
Banco Santander (SAN)
27K → 27K shares (+1%)
Cigna (CI)
1,325 → 1,342 shares (+1%)
VANGUARD SCOTTSDALE FDS
2,585 → 2,890 shares (+12%)
INVESCO EXCHANGE TRADED FD T
5,825 → 6,028 shares (+4%)
Cencora (COR)
1,379 → 1,266 shares (−8%)
Boston Scientific (BSX)
8,658 → 8,236 shares (−5%)